Aging and Cancer

Wiley

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Aging and Cancer is an open-access journal published by Wiley in United States, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,810 EUR. Declared review time at DOAJ: 10 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
2643-8909
Country
United States
Languages
english
Access
Open access
Declared publication charge
2,810 EUR
Articles in DOAJ
64
Declared review time
10 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2022-01-17
Indexing
DOAJ
APC
2,810 EUR
Declared review time (DOAJ)
10 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

64

Most recent article

last month

Average review time (journal-declared via DOAJ)

10weeks

Works in OpenAlex

106

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

12

i10-index

14

From OpenAlex open data (CC0).

Editorial & policy12
Last DOAJ review date
2026-03-17
Added to DOAJ
2022-01-17
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Open references deposited at Crossref
63%
ORCID iDs in current deposits
55%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101770599
Classification4

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogensMedicine: Internal medicine: Special situations and conditions: Geriatrics

LCC codes

RC254-282RC952-954.6

Subject areas

  • Diverse Scientific and Economic Studies
  • Diverse Scientific and Economic Studies
  • Genetics, Aging, and Longevity in Model Organisms
  • Educational Robotics and Engineering
  • Human auditory perception and evaluation
  • Human auditory perception and evaluation
  • Educational Robotics and Engineering
  • Telomeres, Telomerase, and Senescence
Show all subjects (75)
  • Frailty in Older Adults
  • Telomeres, Telomerase, and Senescence
  • Telomeres, Telomerase, and Senescence
  • Frailty in Older Adults
  • Cancer Immunotherapy and Biomarkers
  • Frailty in Older Adults
  • Genetics, Aging, and Longevity in Model Organisms
  • Cancer Immunotherapy and Biomarkers
  • Genetics, Aging, and Longevity in Model Organisms
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Acute Myeloid Leukemia Research
  • Cancer Genomics and Diagnostics
  • Cancer Genomics and Diagnostics
  • Nutrition and Health in Aging
  • Cancer survivorship and care
  • Cancer Genomics and Diagnostics
  • DNA Repair Mechanisms
  • DNA Repair Mechanisms
  • Genetic factors in colorectal cancer
  • Acute Myeloid Leukemia Research
  • Genetic factors in colorectal cancer
  • DNA Repair Mechanisms
  • Cancer Cells and Metastasis
  • Childhood Cancer Survivors' Quality of Life
  • Acute Myeloid Leukemia Research
  • Immune cells in cancer
  • Metabolism, Diabetes, and Cancer
  • Pancreatic and Hepatic Oncology Research
  • Cancer survivorship and care
  • Retinoids in leukemia and cellular processes
  • Immune cells in cancer
  • T-cell and B-cell Immunology
  • Lung Cancer Research Studies
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Gastric Cancer Management and Outcomes
  • Global Cancer Incidence and Screening
  • Pancreatic and Hepatic Oncology Research
  • Childhood Cancer Survivors' Quality of Life
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Nutrition and Health in Aging
  • Pancreatic and Hepatic Oncology Research
  • Cancer survivorship and care
  • Immune cells in cancer
  • Epigenetics and DNA Methylation
  • Cancer Cells and Metastasis
  • Protease and Inhibitor Mechanisms
  • Immune Cell Function and Interaction
  • Protein Degradation and Inhibitors
  • Cutaneous Melanoma Detection and Management
  • Hematopoietic Stem Cell Transplantation
  • Lung Cancer Diagnosis and Treatment
  • Glioma Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Epigenetics and DNA Methylation
  • Nutrition and Health in Aging
  • Immune Cell Function and Interaction
  • Hematopoietic Stem Cell Transplantation
  • Immunotherapy and Immune Responses
  • Hematopoietic Stem Cell Transplantation
  • Cancer Cells and Metastasis
  • Immunotherapy and Immune Responses
  • Cancer-related Molecular Pathways
  • Gut microbiota and health
  • MicroRNA in disease regulation
  • Gut microbiota and health
  • MicroRNA in disease regulation

Keywords (DOAJ)

  • cancer
  • geriatric oncology
  • epigenetics
  • ageing

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: